Literature DB >> 12938585

[Calyceal fistula in a renal allograft treated with N-Butyl-2-cyanoacrylate].

L Riera Canals1, S Arbeláez Arango, C González-Satue, C Sancho, J Domínguez, O Buisan Rueda, N Serrallach Milá.   

Abstract

BACKGROUND: Calyceal fistulas are common and difficult to treat after surgery of urinary collecting system.
METHODS: A 30-year old woman. The fifth day after receiving a cadaver donor renal allograft presented an acute rejection episode; fourteen days later presented an urinoma treated with a percutaneous drainage tube. Five days later surgical exploration was made, lower pole infarction and ischemic necrosis of distal ureter were found. Parcial nephrectomy and neo-ureterovesical anastomosis were performed. Later, an inferior calyceal fistula was evidenced, persisting during several weeks in spite of a percutaneous drainage tube. Under fluoroscopic guidance the fistulous tract was embolized with N-butyl-2-cyanoacrylate.
RESULTS: The fluoroscopic control confirmed the total closure of the fistula. After 22 months no reappearance of the fistula, no stenosis has been shown at this level.
CONCLUSIONS: This is a useful technique for the treatment of calyceal fistulas. This is the first time that N-butyl-2-cyanoacrylate is use in the treatment of a calyceal fistula.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12938585     DOI: 10.1016/s0210-4806(03)72969-6

Source DB:  PubMed          Journal:  Actas Urol Esp        ISSN: 0210-4806            Impact factor:   0.994


  2 in total

1.  Minimally invasive treatment of urinary fistulas using N-butyl-2-cyanoacrylate: a valid first line option.

Authors:  Cesare Selli; Maurizio De Maria; Michele Manica; Filippo Maria Turri; Francesca Manassero
Journal:  BMC Urol       Date:  2013-10-24       Impact factor: 2.264

2.  2-octyl cyanoacrylate versus reintervention for closure of urethrocutaneous fistulae after urethroplasty for hypospadias: a randomized controlled trial.

Authors:  Gabriela Ambriz-González; Pedro Aguirre-Ramirez; José Manuel García-de León; Francisco Javier León-Frutos; Sergio Adrián Montero-Cruz; Xóchitl Trujillo; Clotilde Fuentes-Orozco; Michel Dassaejv Macías-Amezcua; Andrea del Socorro Álvarez-Villaseñor; Ana Olivia Cortés-Flores; Mariana Chávez-Tostado; Alejandro González-Ojeda
Journal:  BMC Urol       Date:  2014-11-21       Impact factor: 2.264

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.